Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States.
Tseng HF, Sy LS, Ackerson BK, Rayens E, Wu J, Luo Y, Cheng Y, Ku JH, Vega Daily LI, Takhar HS, Song J, Cohen RA, Yun H, Oraichi D, Seifert H, Qian L.
Tseng HF, et al. Among authors: luo y.
Clin Infect Dis. 2025 Jun 23:ciaf329. doi: 10.1093/cid/ciaf329. Online ahead of print.
Clin Infect Dis. 2025.
PMID: 40581370